» » Cancer and the Search for Selective Biochemical Inhibitors
Download Cancer and the Search for Selective Biochemical Inhibitors epub book
ISBN:1420045938
Author: E.J. Hoffman
ISBN13: 978-1420045932
Title: Cancer and the Search for Selective Biochemical Inhibitors
Format: lrf mbr mobi txt
ePUB size: 1542 kb
FB2 size: 1179 kb
DJVU size: 1848 kb
Language: English
Category: Medicine
Publisher: CRC Press; 2 edition (June 25, 2007)
Pages: 480

Cancer and the Search for Selective Biochemical Inhibitors by E.J. Hoffman



The text also addresses the problem of determining selective and non-toxic enzyme inhibitors for cancer cell metabolic pathways. Keeping the same format that made its predecessor a benchmark text, this book compares complementary, alternative, and integrative treatments with chemotherapy and other more traditional treatments.

The Warburg Cancer Theory Cell Metabolism Enzyme-Catalyzed Metabolic Pathways Overall Glycolytic Conversions Cancer Cell Metabolism vs. Normal Cell Metabolism Selective Biochemical Inhibitors The Tricarboxylic Cycle and Respiration Vitamins and Hormones as Inhibitors or Promoters Chemotherapy Drugs as Enzyme Inhibitors More on Folic Acid Enzyme Transformations.

Prostate cancer chemoprevention agents exhibit selective activity against early stage prostate cancer cells. YQ Liu1, E Kyle2, S Patel2, F Housseau3, F Hakim2,. Identification of Selective Inhibitors of Cancer Stem. Aug 13, 2009 - CD24low subfraction of cells (Al-Hajj et a. 2003).

Explores bodily biochemical processes, how enzymes and enzyme inhibitors are involved, and how this knowledge assists in the treatment of cancer. Examines how conventional chemotherapy merges with concepts of alternative and complementary medicine. Covers the biochemistry of cancer and how this knowledge can aid patients and practitioners in treatment. Includes some of the more unusual esoterica about cancer and its causes, treatment, and cures

Selective Biochemical Inhibitors. The Tricarboxylic Cycle and Respiration. Vitamins and Hormones as Inhibitors or Promoters. Chemotherapy Drugs as Enzyme Inhibitors. Enzyme Transformations. Histone Diacetylase Inhibitors. Markers for Monitoring Cancer Growth and Remission. Moral and Ethical Quandaries. The Inhibition of Cancerous Stem Cells. The Subject of Stem Cells and Cancer. Cancerous Stem Cells and Immunity. Inhibition of Cancerous Stem Cells. Plant Sources for Tyrosine Kinase Inhibitors.

I think this is probably very useful information but I have an element of doubt about the accuracy of the author’s statements and evaluations. The drug companies may not like what is written but at least can agree with the accuracy of the remarks.

The text also addresses the problem of and non-toxic enzyme inhibitors for cancer cell metabolic pathways. Keeping the same format that made itspredecessor a benchmark text, this book compares complementary, alternative, and s with chemotherapy and other more traditional treatments.

2nd ed. by Edward J. Hoffman. RC. The Physical Object.

Find nearly any book by E. J Hoffman. Get the best deal by comparing prices from over 100,000 booksellers. Concept of Energy: Inquiry into Origins and Applications. ISBN 9780250401536 (978-0-250-40153-6) Hardcover, n, 1977.

The world of medicine has become splintered into two factions, that of orthodoxy and its counterpart, alternative or complementary medicine. A problem with alternative medicine is, of course, that of anecdote and hearsay. The solution: the disclosure, in an unassailable fashion, of the underlying biochemical principles for alternative cancer therapies.

Cancer and the Search for Selective Biochemical Inhibitors, Second Edition delineates the underlying biochemical principles for alternative cancer therapies. Completely revised and updated, this edition includes coverage of the link between concepts and practices of alternative and conventional medicine. The author examines anticancer plant substances and other alternatives such as Vitamin C, essiac tea, shark cartilage, and cat’s claw. The text also addresses the problem of determining selective and non-toxic enzyme inhibitors for cancer cell metabolic pathways.

While an increased number of allopathic professionals are in tune with alternative therapies, the integration of the two factions is far from the norm. Keeping the same format that made its predecessor a benchmark text, this book compares complementary, alternative, and integrative treatments with chemotherapy and other more traditional treatments.